Program Lead

Benjamin Daelken holds a PhD in biochemistry and has more than 13 years of experience in drug development in the pharmaceutical industry. Benjamin worked as a senior director in program leadership, clinical strategy & development and medical affairs in various international assignments. Over the years, Benjamin has worked in immunology, oncology, and anti-infectives. He has also worked across multiple phases of drug development including late-stage development. Benjamin joined Merck in 2018 and is based in Darmstadt, Germany.